Anagenics Ltd has released a press release.
Cellmid Signs Trading Agreement With API/Priceline
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Anagenics
- New TV Shopping Agreement for Evolis
- New Evolis Distribution & Supply Agreements - China & Europe
- FY2019 Financial Results
- Patent for Improved Midkine Antibody Allowed in Europe
- CDY Signs Distribution Agreement for EVOLIS in South Korea
Later from Anagenics
- Cellmid Reports on QVC Sales
- Key Midkine Antibody Patents Granted in the US and Europe
- Appendix 4C and Notes to Appendix 4C
- Cellmids Evolis Patent to be Granted in China
- Appendix 4D, Half Year Accounts and Presentation
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics